Lead Product(s) : Undisclosed
Therapeutic Area : Hematology
Study Phase : Discovery
Sponsor : Lunac Therapeutics
Deal Size : Undisclosed
Deal Type : Partnership
Domainex inks partnership with LUNAC Therapeutics to discover novel anticoagulant therapies
Details : The partnership aims at discovering a drug that inhibits the protease target, activated Factor XII.
Product Name : Undisclosed
Product Type : Undisclosed
Upfront Cash : Undisclosed
February 25, 2020
Lead Product(s) : Undisclosed
Therapeutic Area : Hematology
Highest Development Status : Discovery
Sponsor : Lunac Therapeutics
Deal Size : Undisclosed
Deal Type : Partnership